+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 4Years - 17Years
All Genders
ID05916339

Comparing ADHD Medication Options for Children and Youth With Autism Spectrum Disorder

Led by Daniel Coury · Updated on 2026-10-22

500

Participants Needed

13

Research Sites

51 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness of two stimulant medications, methylphenidate and amphetamine, for treating ADHD in children and adolescents who also have autism spectrum disorder ASD. This study uses a special design called a Sequential Multiple Assignment Randomization Trial SMART to compare these medications and also assess the role of alpha-2 agonists, another class of ADHD medication. The goal is to improve how doctors choose medications and reduce the trial-and-error process that families currently face. Participants are first randomly assigned to receive either an amphetamine or methylphenidate medication, with the specific choice made through discussion between the doctor and the parent or caregiver. If the first medication is not effective or tolerable, participants may be re-randomized to either an alpha-2 agonist or the alternate stimulant. Medications are obtained through the participants pharmacy, and dosing and duration are personalized through discussions between the doctor and family. This study does not involve investigational drugs but rather evaluates commonly prescribed medications. During the study, parents will regularly provide ratings of their childs response to medication using standardized tools such as the Vanderbilt Parent Rating Scale, Clinical Global Impression, and the Aberrant Behavior Checklist. Most assessments are completed electronically to minimize hospital visits. The study aims to gather detailed information over 16 weeks to understand medication effectiveness, side effects, and impacts on behaviors. Participants are children aged 4 to 17 years, and the findings will help improve medication management for children with both ASD and ADHD.

CONDITIONS

Brief Title

AWARE: Management of ADHD in Autism Spectrum Disorder

Research Team

A

Amanda James, BS

S

Samantha Sharpe

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here